Wei Kang
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- RNA modifications and cancer 24
- Epigenetics and DNA Methylation 15
- Cancer-related gene regulation 11
- RNA Research and Splicing 8
- Oncology 32
- Co-authors
- Jun Yu (77 shared papers)Ka‐Fai To (86 shared papers)Alfred S.L. Cheng (36 shared papers)Joseph J.�Y. Sung (27 shared papers)Tingting Huang (17 shared papers)Chi Chun Wong (30 shared papers)Huarong Chen (21 shared papers)Raymond Wai Ming Lung (16 shared papers)
- Journals
- Oncogene (14 papers)Gastroenterology (10 papers)Molecular Cancer (9 papers)Cancer Research (6 papers)The Journal of Pathology (5 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Wei Kang
168 papers receiving 8.9k citations
Wei Kang's Hit Papers
Peers
Comparison fields: 5 of 148
- Cancer Research 2.0k
- Infectious Diseases 1.3k
- Molecular Biology 4.5k
- Oncology 1.3k
- Cell Biology 834
Countries citing papers authored by Wei Kang
This map shows the geographic impact of Wei Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Kang more than expected).
Fields of papers citing papers by Wei Kang
This network shows the impact of papers produced by Wei Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Kang. The network helps show where Wei Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways Hit paper breakdown → | 2004 | 820 |
| 2 | The clinical pathology of severe acute respiratory syndrome (SARS): a report from China Hit paper breakdown → | 2003 | 588 |
| 3 | 2019 | 240 | |
| 4 | 2020 | 233 | |
| 5 | 2011 | 214 | |
| 6 | Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites Hit paper breakdown → | 2022 | 205 |
| 7 | Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets Hit paper breakdown → | 2024 | 196 |
| 8 | 2020 | 195 | |
| 9 | METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer Hit paper breakdown → | 2022 | 188 |
| 10 | 2013 | 187 | |
| 11 | 2015 | 174 | |
| 12 | Targeting m 6 A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer Hit paper breakdown → | 2023 | 173 |
| 13 | 2016 | 157 | |
| 14 | 2020 | 142 | |
| 15 | 2012 | 126 | |
| 16 | 2012 | 125 | |
| 17 | 2018 | 118 | |
| 18 | 2017 | 116 | |
| 19 | 2016 | 110 | |
| 20 | 2015 | 109 |
About Wei Kang
Wei Kang is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Epidemiology, having authored 176 papers that have together received 9.0k indexed citations. Recurring topics across this work include RNA modifications and cancer (24 papers), Hippo pathway signaling and YAP/TAZ (19 papers), Cancer-related molecular mechanisms research (17 papers), Epigenetics and DNA Methylation (15 papers), Cancer-related gene regulation (11 papers), RNA Research and Splicing (8 papers), Genetic factors in colorectal cancer (8 papers) and Antibiotic Resistance in Bacteria (7 papers). The work is most often cited by research in Cancer Research (2.0k citations), Infectious Diseases (1.3k citations), Molecular Biology (4.5k citations), Oncology (1.3k citations) and Cell Biology (834 citations). Wei Kang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Jun Yu, Ka‐Fai To, Alfred S.L. Cheng, Joseph J.�Y. Sung, Tingting Huang, Chi Chun Wong, Huarong Chen, Raymond Wai Ming Lung, Jian Geng and Hui-xia Han. Their work appears in journals such as Oncogene, Gastroenterology, Molecular Cancer, Cancer Research and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.